These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31170144)

  • 21. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.
    Mire CE; Satterfield BA; Geisbert JB; Agans KN; Borisevich V; Yan L; Chan YP; Cross RW; Fenton KA; Broder CC; Geisbert TW
    Sci Rep; 2016 Aug; 6():30916. PubMed ID: 27484128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ChAdOx1 NiV vaccination protects against lethal Nipah Bangladesh virus infection in African green monkeys.
    van Doremalen N; Avanzato VA; Goldin K; Feldmann F; Schulz JE; Haddock E; Okumura A; Lovaglio J; Hanley PW; Cordova K; Saturday G; de Wit E; Lambe T; Gilbert SC; Munster VJ
    NPJ Vaccines; 2022 Dec; 7(1):171. PubMed ID: 36543806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nipah virus: vaccination and passive protection studies in a hamster model.
    Guillaume V; Contamin H; Loth P; Georges-Courbot MC; Lefeuvre A; Marianneau P; Chua KB; Lam SK; Buckland R; Deubel V; Wild TF
    J Virol; 2004 Jan; 78(2):834-40. PubMed ID: 14694115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.
    de Wit E; Feldmann F; Cronin J; Goldin K; Mercado-Hernandez R; Williamson BN; Meade-White K; Okumura A; Callison J; Weatherman S; Rosenke R; Avanzato VA; Lovaglio J; Scott DP; Marzi A; Feldmann H
    EBioMedicine; 2023 Jan; 87():104405. PubMed ID: 36508878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in diagnostics, vaccines and therapeutics for Nipah virus.
    Thakur N; Bailey D
    Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancements in Nipah virus treatment: Analysis of current progress in vaccines, antivirals, and therapeutics.
    Mishra G; Prajapat V; Nayak D
    Immunology; 2024 Feb; 171(2):155-169. PubMed ID: 37712243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
    Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
    J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8.
    Watanabe S; Yoshikawa T; Kaku Y; Kurosu T; Fukushi S; Sugimoto S; Nishisaka Y; Fuji H; Marsh G; Maeda K; Ebihara H; Morikawa S; Shimojima M; Saijo M
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011851. PubMed ID: 38100536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.
    Monath TP; Nichols R; Tussey L; Scappaticci K; Pullano TG; Whiteman MD; Vasilakis N; Rossi SL; Campos RK; Azar SR; Spratt HM; Seaton BL; Archambault WT; Costecalde YV; Moore EH; Hawks RJ; Fusco J
    PLoS Pathog; 2022 Jun; 18(6):e1010658. PubMed ID: 35759511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of an RNA polymerase II-driven reverse genetics system for Nipah virus strains from Malaysia and Bangladesh.
    Griffin BD; Leung A; Chan M; Warner BM; Ranadheera C; Tierney K; Audet J; Frost KL; Safronetz D; Embury-Hyatt C; Booth SA; Kobasa D
    Sci Rep; 2019 Aug; 9(1):11171. PubMed ID: 31371748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions.
    Baseler L; de Wit E; Scott DP; Munster VJ; Feldmann H
    Vet Pathol; 2015 Jan; 52(1):38-45. PubMed ID: 25352203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.
    Ploquin A; Szécsi J; Mathieu C; Guillaume V; Barateau V; Ong KC; Wong KT; Cosset FL; Horvat B; Salvetti A
    J Infect Dis; 2013 Feb; 207(3):469-78. PubMed ID: 23175762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease.
    Woolsey C; Borisevich V; Fears AC; Agans KN; Deer DJ; Prasad AN; O'Toole R; Foster SL; Dobias NS; Geisbert JB; Fenton KA; Cross RW; Geisbert TW
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36445779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newcastle disease virus-vectored Nipah encephalitis vaccines induce B and T cell responses in mice and long-lasting neutralizing antibodies in pigs.
    Kong D; Wen Z; Su H; Ge J; Chen W; Wang X; Wu C; Yang C; Chen H; Bu Z
    Virology; 2012 Oct; 432(2):327-35. PubMed ID: 22726244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.
    Singh RK; Dhama K; Chakraborty S; Tiwari R; Natesan S; Khandia R; Munjal A; Vora KS; Latheef SK; Karthik K; Singh Malik Y; Singh R; Chaicumpa W; Mourya DT
    Vet Q; 2019 Dec; 39(1):26-55. PubMed ID: 31006350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Status of vaccine research and development of vaccines for Nipah virus.
    Satterfield BA; Dawes BE; Milligan GN
    Vaccine; 2016 Jun; 34(26):2971-2975. PubMed ID: 26973068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Griffithsin Inhibits Nipah Virus Entry and Fusion and Can Protect Syrian Golden Hamsters From Lethal Nipah Virus Challenge.
    Lo MK; Spengler JR; Krumpe LRH; Welch SR; Chattopadhyay A; Harmon JR; Coleman-McCray JD; Scholte FEM; Hotard AL; Fuqua JL; Rose JK; Nichol ST; Palmer KE; O'Keefe BR; Spiropoulou CF
    J Infect Dis; 2020 May; 221(Supplement_4):S480-S492. PubMed ID: 32037447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.